Cite Filings / HALO / 0001950047-24-006333
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

HALOZYME THERAPEUTICS, INC. · Filed 2024-08-21 · Acc 0001950047-24-006333

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2024-09-10 144 Sale of Securities
  • 2024-08-27 4 SVP, CHIEF TECHNICAL OFFICER acquired 5,580 shares (option exercise)
  • 2024-08-21 144 Sale of Securities
  • 2024-08-21 4 SVP, CHIEF TECHNICAL OFFICER sold 20,000 shares at an average $61.40 ($1,228,020)
  • 2024-08-20 144 Sale of Securities
  • 2024-08-15 144 Sale of Securities
  • 2024-08-15 4 PRESIDENT AND CEO sold 30,000 shares at an average $57.15 ($1,714,451)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…